{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T15:02:35Z","timestamp":1766674955802},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Development and Innovation Operative Programme of Hungary"},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["OTKA K","109107"],"award-info":[{"award-number":["OTKA K","109107"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.steroids.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T18:07:29Z","timestamp":1521828449000},"page":"79-91","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Synthesis of novel 17-triazolyl-androst-5-en-3-ol epimers via Cu(I)-catalyzed azide-alkyne cycloaddition and their inhibitory effect on 17\u03b1-hydroxylase\/C 17,20 -lyase"],"prefix":"10.1016","volume":"135","author":[{"given":"Anita","family":"Kiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianka Edina","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"G\u00f6rbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erzs\u00e9bet","family":"Merny\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barnab\u00e1s","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"W\u00f6lfling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mih\u00e1ly","family":"Sz\u00e9csi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyula","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2018.03.006_b0005","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2174\/1568026611313120002","article-title":"CYP17A1: a biochemistry, chemistry, and clinical review","volume":"13","author":"Porubec","year":"2013","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/187152009788680046","article-title":"17\u03b1-Hydroxylase\/17,20-lyase (P45017\u03b1) inhibitors in the treatment of prostate cancer: a review","volume":"9","author":"Owen","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.steroids.2014.12.021","article-title":"CYP17A1 inhibitors in castration-resistant prostate cancer","volume":"95","author":"Gomez","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1758834016642370","article-title":"CYP17 inhibitors in prostate cancer: latest evidence and clinical potential","volume":"8","author":"Alex","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.steroids.2018.03.006_b0025","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2174\/092986708783955428","article-title":"CYP17 inhibitors for prostate cancer treatment-an update","volume":"15","author":"Moreira","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/157489207779561453","article-title":"Inhibitors of steroidal cytochrome P450 enzymes as a targets for drug development","volume":"2","author":"Baston","year":"2007","journal-title":"Recent Pat. Anti-Cancer Drug Discovery"},{"key":"10.1016\/j.steroids.2018.03.006_b0035","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1021\/jm981017j","article-title":"The 16,17-double bond is needed for irreversible inhibition of human cytochrom P45017\u03b1 by abirateron (17-(3-pyridyl)androsta-5,16-dien- 3\u03b2-ol) and related steroidal inhibitors","volume":"41","author":"Jarman","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0040","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0045","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1021\/jm040202w","article-title":"Novel C-17 heteroaryl steroidal CYP17 inhibitors\/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model","volume":"48","author":"Handratta","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0050","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.steroids.2008.06.011","article-title":"Neighboring group participation Part 17 Stereoselective synthesis of some steroidal 2-oxazolidones, as novel potential inhibitors of 17\u03b1-hydroxylase-C17,20-lyase","volume":"73","author":"Ondr\u00e9","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0055","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.steroids.2009.08.001","article-title":"Stereoselective synthesis of some steroidal oxazolines, as novel potential inhibitors of 17\u03b1- hydroxylase-C17,20-lyase","volume":"74","author":"Ondr\u00e9","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.steroids.2010.02.013","article-title":"Synthesis of regioisomeric 17\u03b2-N-phenylpyrazolyl steroid derivatives and their inhibitory effect on 17\u03b1- hydroxylase\/C17,20-lyase","volume":"75","author":"Iv\u00e1nyi","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0065","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.steroids.2012.02.001","article-title":"Synthesis of D-ring-substituted (5\u2019R)- and (5\u2019S)-17\u03b2-pyrazolynylandrostene epimers and comparison of their potential anticancer activities","volume":"77","author":"Iv\u00e1nyi","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0070","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.steroids.2012.07.001","article-title":"Novel series of 17\u03b2- pyrazolylandrosta-5,16-diene derivatives and their inhibitory effect on 17\u03b1- hydroxylase\/C17,20-lyase","volume":"77","author":"Iv\u00e1nyi","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.steroids.2015.03.008","article-title":"Synthesis of methoxycarbonylpirazolylandrostene derivatives, and their potencial inhibitory effect on androgen biosynthesis and cell proliferation","volume":"98","author":"Szab\u00f3","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0080","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise Huisgen cycloaddition process: Copper(I)-catalyzed regioselectivity \u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostostsev","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.steroids.2018.03.006_b0085","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1021\/jo011148j","article-title":"Peptidotriazoles on solid phase: [1,2,3]- triazoles by regiospecific copper(I)-catalized 1,3-dipolar cycloadditions on terminal alkynes to azides","volume":"67","author":"Torn\u00f8e","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.steroids.2011.05.002","article-title":"Synthesis of steroidal 17\u03b1-triazolyl derivatives via Cu(I)-catalyzed azide-alkyne cycloaddition, and an evaluation of their cytotoxic activity in vitro","volume":"76","author":"Frank","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0095","first-page":"71","article-title":"Neighbouring group participation, IV. Preparation of 16\u03b1-hydroxymethylandrost-5-ene-3\u03b2,17\u03b1-diol","volume":"109","author":"Schneider","year":"1982","journal-title":"Acta Chim. Acad. Sci. Hung."},{"key":"10.1016\/j.steroids.2018.03.006_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1556\/ABiol.66.2015.1.4","article-title":"Determination of 17\u03b1-hydroxylase-C17,20- lyase (P45017\u03b1) enzyme activities and their inhibition by selected steroidal picolyl and picolinylidene compounds","volume":"66","author":"Szab\u00f3","year":"2015","journal-title":"Acta Biol. Hung"},{"key":"10.1016\/j.steroids.2018.03.006_b0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.steroids.2015.02.018","article-title":"Synthesis of novel 17-(5\u2019-iodo)triazolyl-3-methoxyestra epimers via Cu(I)-catalyzed azide-alkyne cycloaddition, and evaluation of their cytotoxyc activity in vitro","author":"Schneider","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0110","series-title":"Cancer Drug Design and Discovery","first-page":"319","article-title":"The Renaissance of CYP17 Inhibitors for the Treatment of Prostate Cancer","author":"Hu","year":"2014"},{"key":"10.1016\/j.steroids.2018.03.006_b0115","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/jm970337k","article-title":"17-Imidazolyl, pyrazolyl, and isoxazolyl androstane derivatives: novelsteroidal inhibitors of human cytochrome C17,20-lyase (P450 17\u03b1)","volume":"40","author":"Ling","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/jm970568r","article-title":"Novel azolyl steroids, potent inhibitors of human cytochrome 17\u03b1-hydroxylase-C17,20-lyase (P450 17\u03b1): potential agents for the treatment of prostate cancer","volume":"41","author":"Njar","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0960-0760(99)00129-6","article-title":"Effect of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo","volume":"71","author":"Nnane","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2018.03.006_b0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancers drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2018.03.006_b0135","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/jm501239f","article-title":"Discovery and development of Galeterone (TOK-001 or VN\/124- 1) for the treatment of all stages of prostate cancer","volume":"58","author":"Njar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0140","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1021\/jm040202w","article-title":"Novel C-17-heteroaryl steroidal CYP17 inhibitors\/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograf model","volume":"48","author":"Handratta","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0145","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10600-008-9126-8","article-title":"Synthesis and antituberculosis activity of certain steroidal derivatives of the 5\u03b1-series","volume":"44","author":"Merlani","year":"2008","journal-title":"Chem. Nat. Compd."},{"key":"10.1016\/j.steroids.2018.03.006_b0150","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.steroids.2011.04.008","article-title":"Azido analogs of neuroactive steroids","volume":"76","author":"Vidrna","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2018.03.006_b0155","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/jm501239f","article-title":"Discovery and development of galeterone (TOK-001 or VN\/124-1) for the treatment of all stages of prostate cancer","volume":"58","author":"Njar","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2018.03.006_b0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/bj2730533","article-title":"'Slow-binding' sixth-ligand inhibitors of cytochrome P-450 aromatase. Studies with 19-thiomethyl- and 19-azido-androstenedione","volume":"273","author":"Wright","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.steroids.2018.03.006_b0165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1039\/C5SC02857D","article-title":"Efficient conversion of primary azides to aldehydes Catalysed by active site variants of myoglobin","volume":"7","author":"Giovanni","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.steroids.2018.03.006_b0170","first-page":"3994","article-title":"The effect of ketoconazole on adrenal and testicular steroidgenesis in vitro","volume":"35","author":"Lamber","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.steroids.2018.03.006_b0175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cbdd.12195","article-title":"N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines","volume":"82","author":"Brossard","year":"2013","journal-title":"Chem. Biol. Drug Des."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1830059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1830059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T21:51:18Z","timestamp":1534974678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X1830059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":35,"alternative-id":["S0039128X1830059X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2018.03.006","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel 17-triazolyl-androst-5-en-3-ol epimers via Cu(I)-catalyzed azide-alkyne cycloaddition and their inhibitory effect on 17\u03b1-hydroxylase\/C17,20-lyase","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}